Solara Active Pharma Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for API Expertise for more than 30 Years, with 4 Manufacturing Facilities armed with Global Approvals.
One of their notable products is KETOPROFEN USP, with a corresponding US DMF Number 24179.
Remarkably, this DMF maintains an Active status since its submission on September 14, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 05, 2013, and payment made on August 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II